Effects of Tigecycline Combined with Azithromycin Against Biofilms of Multidrug-Resistant Stenotrophomonas maltophilia Isolates from a Patient in China

References

• Chang Y, Lin C, Chen Y, Hsueh P. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol. 2015;6:893. doi:10.3389/fmicb.2015.0089326388847
   PubMed Web of Science ®Google Scholar
• Jeon YD, Jeong WY, Kim MH, et al. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia. Medicine. 2016;95(31):e4375. doi:10.1097/MD.000000000000437527495046
   PubMed Web of Science ®Google Scholar
• Hu L, Xu X, Li H, et al. Surveillance of antimicrobial susceptibility patterns among Stenotrophomonas maltophilia isolated in China during the 10-year period of 2005–2014. J Chemother. 2018;30(1):25–30. doi:10.1080/1120009X.2017.137883428949279
   PubMed Web of Science ®Google Scholar
• Kang YR, Cha YK, Kim JS, et al. Imaging findings ofStenotrophomonas maltophilia pneumonia: emphasis on CT findings between immunocompromised and immunocompetent patients. Acta Radiol. 2020;61(7):903–909. doi:10.1177/028418511988511731698928
   PubMed Web of Science ®Google Scholar
• Adegoke AA, Stenström TA, Okoh AI. Stenotrophomonas maltophilia as an emerging ubiquitous pathogen: looking beyond contemporary antibiotic therapy. Front Microbiol. 2017;8. doi:10.3389/fmicb.2017.02276
   Web of Science ®Google Scholar
• Cabaret O, Bonnal C, Canoui-Poitrine F, et al. Concomitant presence of aspergillus fumigatus and Stenotrophomonas maltophilia in the respiratory tract: a new risk for patients with liver disease? J Med Microbiol. 2016;65(5):414–419. doi:10.1099/jmm.0.00023326872817
   PubMed Web of Science ®Google Scholar
• Saini H, Chhibber S, Harjai K. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections. Int J Antimicrob Agents. 2015;45(4):359–367. doi:10.1016/j.ijantimicag.2014.11.00825604277
   PubMed Web of Science ®Google Scholar
• Wang A, Wang Q, Kudinha T, Xiao S, Zhuo C. Effects of fluoroquinolones and azithromycin on biofilm formation of Stenotrophomonas maltophilia. Sci Rep. 2016;6(1).
   Google Scholar
• Sun E, Liang G, Wang L, et al. Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms. Braz J Infect Dis. 2016;20(4):365–373. doi:10.1016/j.bjid.2016.04.00227183359
   PubMed Web of Science ®Google Scholar
• Nichols DP, Caceres S, Caverly L, et al. Effects of azithromycin in Pseudomonas aeruginosa burn wound infection. J Surg Res. 2013;183(2):767–776. doi:10.1016/j.jss.2013.02.00323478086
   PubMed Web of Science ®Google Scholar
• Roisin L, Melloul E, Woerther P, et al. Modulated response of aspergillus fumigatus and Stenotrophomonas maltophilia to antimicrobial agents in polymicrobial biofilm. Front Cell Infect Microbiol. 2020;10.
   Web of Science ®Google Scholar
• Mah T. Biofilm-specific antibiotic resistance. Future Microbiol. 2012;7(9):1061–1072. doi:10.2217/fmb.12.7622953707
   PubMed Web of Science ®Google Scholar
• Olsen I. Biofilm-specific antibiotic tolerance and resistance. Eur J Clin Microbiol. 2015;34(5):877–886. doi:10.1007/s10096-015-2323-z
   Google Scholar
• Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167–193. doi:10.1128/CMR.15.2.167-193.200211932229
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Third Informational Supplement, M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute; 2013.
   Google Scholar
• Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52(1):1. doi:10.1093/jac/dkg30112805255
   PubMed Web of Science ®Google Scholar
• Di Bonaventura G, Spedicato I, D’Antonio D, Robuffo I, Piccolomini R. Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. Antimicrob Agents Chemother. 2004;48(1):151–160. doi:10.1128/AAC.48.1.151-160.200414693533
   PubMed Web of Science ®Google Scholar
• O’Toole GA, Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol. 1998;30(2):295–304. doi:10.1046/j.1365-2958.1998.01062.x9791175
   PubMed Web of Science ®Google Scholar
• Passerini DRB, Calenda M, Vay C, Franco M. Biofilm formation by Stenotrophomonas maltophilia isolates from device-associated nosocomial infections. Rev Argent Microbiol. 2007;39(4):204–212.18390153
   PubMedGoogle Scholar
• Melloul E, Luiggi S, Anaïs L, et al. Characteristics of aspergillus fumigatus in association with stenotrophomonas maltophilia in an in vitro model of mixed biofilm. PLoS One. 2016;11(11):e166325. doi:10.1371/journal.pone.0166325
   PubMed Web of Science ®Google Scholar
• Zhuo C, Zhao QY, Xiao SN. The impact of spgM, rpfF, rmlA gene distribution on biofilm formation in Stenotrophomonas maltophilia. PLoS One. 2014;9(10):e108409. doi:10.1371/journal.pone.010840925285537
   PubMed Web of Science ®Google Scholar
• Stepanovic S, Cirkovic I, Ranin L, Svabic-Vlahovic M. Biofilm formation by Salmonella spp. and Listeria monocytogenes on plastic surface. Lett Appl Microbiol. 2004;38(5):428–432. doi:10.1111/j.1472-765X.2004.01513.x15059216
   PubMed Web of Science ®Google Scholar
• Kim H, Lee D, Eom Y. Anti-biofilm and anti-virulence efficacy of celastrol against Stenotrophomonas maltophilia. Int J Med Sci. 2018;15(6):617–627. doi:10.7150/ijms.2392429725253
   PubMed Web of Science ®Google Scholar
• Runci F, Bonchi C, Frangipani E, Visaggio D, Visca P. Acinetobacter baumannii biofilm formation in human serum and disruption by gallium. Antimicrob Agents Chemother. 2017;61(1). doi:10.1128/AAC.01563-16
   Web of Science ®Google Scholar
• Melloul E, Roisin L, Durieux M, et al. Interactions of Aspergillus fumigatus and Stenotrophomonas maltophilia in an in vitro mixed biofilm model: does the strain matter? Front Microbiol. 2018;9. doi:10.3389/fmicb.2018.02850
   Web of Science ®Google Scholar
• Woo S, Lee S, Lee S, Lim K, Ha E, Eom Y. Activity of novel inhibitors of Staphylococcus aureus biofilms. Folia Microbiol. 2017;62(2):157–167. doi:10.1007/s12223-016-0485-427864779
   PubMed Web of Science ®Google Scholar
• Del Carpio-Perochena AE, Bramante CM, Duarte MAH, et al. Biofilm dissolution and cleaning ability of different irrigant solutions on intraorally infected dentin. J Endod. 2011;37(8):1134–1138. doi:10.1016/j.joen.2011.04.01321763908
   PubMed Web of Science ®Google Scholar
• Nosyk O, Ter Haseborg E, Metzger U, Frimmel FH. A standardized pre-treatment method of biofilm flocs for fluorescence microscopic characterization. J Microbiol Methods. 2008;75(3):449–456. doi:10.1016/j.mimet.2008.07.02418718852
   PubMed Web of Science ®Google Scholar
• Liu Y, Jiang Y, Zhu J, Huang J, Zhang H. Inhibition of bacterial adhesion and biofilm formation of sulfonated chitosan against Pseudomonas aeruginosa. Carbohydr Polym. 2019;206:412–419. doi:10.1016/j.carbpol.2018.11.01530553340
   PubMed Web of Science ®Google Scholar
• Balcázar JL, Subirats J, Borrego CM. The role of biofilms as environmental reservoirs of antibiotic resistance. Front Microbiol. 2015;6. doi:10.3389/fmicb.2015.01216
   Web of Science ®Google Scholar
• Romero R, Schaudinn C, Kusanovic JP, et al. Detection of a microbial biofilm in intraamniotic infection. Am J Obstet Gynecol. 2008;198(1):131–135. doi:10.1016/j.ajog.2007.11.026
   Web of Science ®Google Scholar
• Wu K, Yau YCW, Matukas L, Waters V. Biofilm compared to conventional antimicrobial susceptibility of stenotrophomonas maltophilia isolates from cystic fibrosis patients. Antimicrob Agents Chemother. 2013;57(3):1546–1548. doi:10.1128/AAC.02215-1223295930
   PubMed Web of Science ®Google Scholar
• Flores-Treviño S, Bocanegra-Ibarias P, Camacho-Ortiz A, Morfín-Otero R, Salazar-Sesatty HA, Garza-González E. Stenotrophomonas maltophilia biofilm: its role in infectious diseases. Expert Rev Anti Infect Ther. 2019;17(11):877–893. doi:10.1080/14787210.2019.168587531658838
   PubMed Web of Science ®Google Scholar
• Mah TC, O’Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001;9(1):34–39. doi:10.1016/S0966-842X(00)01913-211166241
   PubMed Web of Science ®Google Scholar
• Huang T, Somers EB, Wong ACL. Differential biofilm formation and motility associated with lipopolysaccharide/exopolysaccharide-coupled biosynthetic genes in Stenotrophomonas maltophilia. J Bacteriol. 2006;188(8):3116–3120. doi:10.1128/JB.188.8.3116-3120.200616585771
   PubMed Web of Science ®Google Scholar
• Ciacci N, Boncompagni S, Valzano F, et al. In vitro synergism of colistin and N-acetylcysteine against Stenotrophomonas maltophilia. Antibiotics. 2019;8(3):101. doi:10.3390/antibiotics8030101
   Web of Science ®Google Scholar
• Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25(1):2–41.22232370
   PubMed Web of Science ®Google Scholar
• Minardi D, Montanari MP, Tili E, et al. Effects of fluoroquinolones on bacterial adhesion and on preformed biofilm of strains isolated from urinary double J stents. J Chemother. 2008;20(2):195–201. doi:10.1179/joc.2008.20.2.19518467245
   PubMed Web of Science ®Google Scholar
• Ackermann M. A functional perspective on phenotypic heterogeneity in microorganisms. Nat Rev Microbiol. 2015;13(8):497–508. doi:10.1038/nrmicro349126145732
   PubMed Web of Science ®Google Scholar
• Tu QP, Genevaux P, Pajunen M, et al. Isolation and characterization of biofilm formation-defective mutants of Staphylococcus aureus. Infect Immun. 2007;75(3):1079–1088. doi:10.1128/IAI.01143-0617158901
   PubMed Web of Science ®Google Scholar
• Ishida H, Ishida Y, Kurosaka Y, Otani T, Sato K, Kobayashi H. In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1998;42(7):1641–1645. doi:10.1128/AAC.42.7.16419660997
   PubMed Web of Science ®Google Scholar
• Aaron SD, Ferris W, Ramotar K, Vandemheen K, Chan F, Saginur R. Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis. J Clin Microbiol. 2002;40(11):4172–4179. doi:10.1128/JCM.40.11.4172-4179.200212409393
   PubMed Web of Science ®Google Scholar
• Carsenti-Etesse H, Durant J, Entenza J, et al. Effects of subinhibitory concentrations of vancomycin and teicoplanin on adherence of staphylococci to tissue culture plates. Antimicrob Agents Chemother. 1993;37(4):921–923. doi:10.1128/AAC.37.4.9218494393
   PubMed Web of Science ®Google Scholar